★ Featured Topics​Biotechnology & Healthcare

CRISPR Hits Another Snag; But It’s Two Steps Forward, One Step Back

Click here to read the full dibs report

Summary: Market reaction to a report that cells edited with CRISPR technology can activate a cancer-causing gene has been severe for companies developing CRISPR-based therapies. But, the nascent industry has faced and survived such challenges before. Meanwhile, new tools are making gene therapies faster, easier and more accessible than ever, and lowering the industry’s barriers to entry.
Biotech companies developing CRISPR-based therapies received a massive blow this week after new research w...

 

To read more, sign up for a Free 30-Day Trial of MRP's research here.